
Robin Roehm, CEO and co-founder of Apheris, joins us to explore how federated learning is transforming data collaboration in life sciences.
We discuss its impact on drug discovery and clinical trials, the balance between IP protection and AI innovation, and Robin’s journey at the crossroads of tech and healthcare.